Invasive Meningococcal Disease: What We Should Know, Before It Comes Back

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

Erythema nodosum :what should we consider about it?

What we should know about bifurcation disease.

ith great interest we read the article by Li et al. (1) regarding asomotor functional responses of a conduit coronary artery distal o sirolimus-eluting stents in a porcine model. The researchers tated in the discussion, “. . .most of the drug taken up into cardiac issue was transferred by direct contact with the arterial wall, which ay have served as a reservoir for subsequent transfer via diff...

what should we know in bipps

cushing’s syndrome is a rare endocrine disease characterized by hypercortisolemia caused by excess acth secreted by the pituitary. distinguishing pituitary sources from the ectopic sources of acth is challenging because of the limited accuracy of noninvasive assays. the test that offers the highest sensitivity and specificity is bilateral inferior petrosal sinus sampling (bipss). in patients wi...

molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

invasive aspergillosis (ia) are a major complication in immunocompromized patients where can be serious and rapidly fatal. early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. but despite many efforts to develop detection methods, the diagnosis of ia still remains challenging and current conventional methods are limited for adequate diagno...